Ironwood Pharmaceuti (IRWD) Stock Price, Quote & News

Company Profile

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA na...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 617 621 7722

Fax: 617 494 0480

Website: ironwoodpharma.com

Address:

100 Summer Street, Suite 2300, Boston, United States

Solaf Feb. 26 at 9:36 AM

$IRWD this c-suite could not even run a lemonade stand.

0 · Reply

BullsOnPrade Feb. 26 at 2:38 AM

$IRWD this summed up today’s price action

0 · Reply

TeeMan123 Feb. 26 at 2:00 AM

$IRWD shell shocked. Nothing makes sense. How Tom/Mike have the guts to keep going is outstanding. How they set such insanely high Linz guidance with little room of failure is outstanding. How they are re-doing apra with out a cash infusion is outstanding. Sure as hell hope they were trying to talk up a bid with today’s call, otherwise these folks have lost their minds.

1 · Reply

Estimize Feb. 25 at 11:06 PM

$IRWD reported -0.01 EPS and 47.71 revenue for Q4. http://www.estimize.com/intro/irwd?chart=historical&metric_name=eps&utm_content=IRWD&utm

0 · Reply

BlakeCanyon50 Feb. 25 at 10:26 PM

$IRWD I took a substantial position this morning. I caught it slightly under $3. I need this to run up about 100% so I never have to work again, thanks.

0 · Reply

Eskouvion Feb. 25 at 7:42 PM

$IRWD You're buying a cash machine with a free Phase 3 pipeline. Don't let the algorithms fool you. 💰🔥

0 · Reply

ASKING7 Feb. 25 at 7:27 PM

$IRWD despite how disappointed ppl are here, the best practice is to give the market some time to digest the news. Today the shares will mainly shifting from the swing traders who expect the BO to Mid Long term value investors, let’s wait the transition is done, the SP will reflect on that later.

0 · Reply

_FullMooners Feb. 25 at 7:05 PM

$IRWD $AEHR $FLNC $RYAM s

0 · Reply

Young_Antarian Feb. 25 at 6:55 PM

$IRWD gift under $4. These prices wont stick around for very long imo

0 · Reply

flyinghollaender Feb. 25 at 6:42 PM

$IRWD „That being said, we are obviously always open to alternatives that would increase shareholder value“

0 · Reply

Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2025 Earnings Call Transcript

Feb 25, 2026, 7:05 AM EST - 1 day ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Results; Achieves 2025 Financial Guidance and Reiterates Strong 2026 Outlook

Feb 18, 2026, 4:21 PM EST - 7 days ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call

Jan 2, 2026, 7:05 AM EST - 7 weeks ago

Ironwood Pharmaceuticals Maintains FY 2025 Financial Guidance and Announces FY 2026 Financial Guidance

Nov 26, 2025, 4:03 PM EST - 3 months ago

Ironwood Pharmaceuticals: Today's Gains Seem Sustainable After Disastrous First Half Of 2025

Nov 10, 2025, 7:05 AM EST - 3 months ago

Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Oct 24, 2025, 8:10 AM EDT - 4 months ago

Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta

Aug 7, 2025, 7:05 AM EDT - 7 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

May 7, 2025, 7:05 AM EDT - 10 months ago

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

Apr 30, 2025, 4:25 PM EDT - 10 months ago

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 25, 2025, 7:05 AM EDT - 10 months ago

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Apr 22, 2025, 4:05 PM EDT - 11 months ago

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Apr 14, 2025, 2:19 PM EDT - 11 months ago

Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug

Apr 14, 2025, 7:00 AM EDT - 11 months ago

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Apr 10, 2025, 10:49 AM EDT - 11 months ago

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Mar 25, 2025, 8:30 AM EDT - 1 year ago

Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund

Feb 27, 2025, 11:21 AM EST - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 1 year ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Feb 20, 2025, 4:00 PM EST - 1 year ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Jan 29, 2025, 4:05 PM EST - 1 year ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Jan 17, 2025, 8:07 AM EST - 1 year ago

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Nov 26, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 13, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Nov 7, 2024, 10:34 PM EST - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 1 year ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Oct 28, 2024, 7:00 AM EDT - 1 year ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Oct 24, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

Aug 29, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

Aug 9, 2024, 12:10 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Jul 25, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Jun 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation

Jun 26, 2024, 3:30 PM EDT - 1 year ago

The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue

Jun 25, 2024, 2:45 PM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact

Jun 24, 2024, 4:45 PM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication

Jun 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect

Jun 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out

Jun 20, 2024, 1:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC

Jun 19, 2024, 4:20 PM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact

Jun 18, 2024, 4:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 11, 2024, 7:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 9, 2024, 11:00 AM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Urges Investors With Losses To Contact Them

Jun 8, 2024, 11:00 AM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch

Jun 7, 2024, 3:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Contact Them

Jun 6, 2024, 1:00 PM EDT - 1 year ago

Accusations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Investigation And Invites Investors With Losses To Reach Out

Jun 5, 2024, 1:30 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect

Jun 4, 2024, 3:00 PM EDT - 1 year ago

The Schall Law Firm Declares an Inquiry into Accusations Against Ironwood Pharmaceuticals, Inc. and Advocates for Investors with Losses to Reach Out

Jun 2, 2024, 11:00 AM EDT - 1 year ago

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Solaf Feb. 26 at 9:36 AM

$IRWD this c-suite could not even run a lemonade stand.

0 · Reply

BullsOnPrade Feb. 26 at 2:38 AM

$IRWD this summed up today’s price action

0 · Reply

TeeMan123 Feb. 26 at 2:00 AM

1 · Reply

Estimize Feb. 25 at 11:06 PM

$IRWD reported -0.01 EPS and 47.71 revenue for Q4. http://www.estimize.com/intro/irwd?chart=historical&metric_name=eps&utm_content=IRWD&utm

0 · Reply

BlakeCanyon50 Feb. 25 at 10:26 PM

$IRWD I took a substantial position this morning. I caught it slightly under $3. I need this to run up about 100% so I never have to work again, thanks.

0 · Reply

Eskouvion Feb. 25 at 7:42 PM

$IRWD You're buying a cash machine with a free Phase 3 pipeline. Don't let the algorithms fool you. 💰🔥

0 · Reply

ASKING7 Feb. 25 at 7:27 PM

0 · Reply

_FullMooners Feb. 25 at 7:05 PM

$IRWD $AEHR $FLNC $RYAM s

0 · Reply

Young_Antarian Feb. 25 at 6:55 PM

$IRWD gift under $4. These prices wont stick around for very long imo

0 · Reply

flyinghollaender Feb. 25 at 6:42 PM

$IRWD „That being said, we are obviously always open to alternatives that would increase shareholder value“

0 · Reply

revuelto Feb. 25 at 6:21 PM

$IRWD I am sure the tutes are breathing down their necks…I know I would be…expecting a graceful end to the gs drama any moment👍

1 · Reply

jskstocks Feb. 25 at 6:11 PM

$IRWD I predict we stay on the $3.10 - $3.40 trading zone for quite some time, until they can make investors believe they can hit the projected number (or a buyer). A dip below 3 is possible, but I think it is unlikely

0 · Reply

Swamp_Rat Feb. 25 at 5:17 PM

$IRWD catching my interest here.

0 · Reply

Facade78 Feb. 25 at 5:09 PM

$IRWD i would like to see RLYB like move next days !

0 · Reply

Eskouvion Feb. 25 at 4:45 PM

$IRWD Stacking shares. Added 300 more today at 3,05. My work here is done

0 · Reply

wtzou Feb. 25 at 4:25 PM

$IRWD so 3 day slide and then we rebuild. Tom McCourt sucks. Denner sucks. This management are a bunch of idiots. I see $2.50 by Friday

2 · Reply

flyinghollaender Feb. 25 at 3:21 PM

$IRWD bought more at 3.1 and 3.3 - will keep holding

0 · Reply

P2W6zero Feb. 25 at 3:09 PM

$IRWD took all the rest of my shares in 3.48. dont wait or you will have pain

0 · Reply

Solaf Feb. 25 at 3:08 PM

$IRWD These C-suite idiots thought the share price boosted above $5 because of their Q3 linzess number only. WRONG. Market thought they might actually do something good and sell the company for 1-1,5bil+ mcap. Market thought even those eunuchs could persuade FDA for a shorter trial after all the positive news about regulations. Ofc they could not. Now we are left again with too much uncertainty. Can they hit linzess sales numbers ? What if Stars-2 secondaries do not meet Again ? We are left in the limbo another 6 months.

1 · Reply

Bio_Invest101 Feb. 25 at 2:57 PM

$IRWD I say this with all seriousness that retails are just dumb and not deserve to make big money. Don’t be surprised when the SP turns green Btw that BK specialist revuelto starts telling you it’s going to $1 ? Just like he promised you all that IRWD going to $0 And going bankrupt back in 10 months ago Just fucking stupid

0 · Reply

raylin Feb. 25 at 2:54 PM

$IRWD Sarrisa getting smoked in Amrn too. Denner magic vanished after the affair. Ahole!

0 · Reply

revuelto Feb. 25 at 2:45 PM

$IRWD if there’s a pr saying the m&a process has stalled this could revisit the low $1’s…so yes for now, let the investor strategy ride on hope 😀

0 · Reply

Market Cap	616.55M
Revenue (ttm)	351.41M
Net Income (ttm)	880,000.00
EPS (ttm)	N/A
PE Ratio	14.42
Forward PE	4.93
Profit Margin	0.25%
Debt to Equity Ratio	-2.21

Volume	11,572,700
Avg Vol	4,813,712
Day's Range	N/A - N/A
Shares Out	162.68M
Stochastic %K	21%
Beta	0.17
Analysts	Sell
Price Target	$4.28